| Primary |
| Product Used For Unknown Indication |
26.8% |
| Schizophrenia |
17.5% |
| Schizoaffective Disorder |
11.3% |
| Depression |
7.2% |
| Mental Disorder |
7.2% |
| Drug Use For Unknown Indication |
5.2% |
| Psychotic Disorder |
4.1% |
| Bipolar Disorder |
3.1% |
| Convulsion |
3.1% |
| Hypertension |
3.1% |
| Insomnia |
3.1% |
| Schizophrenia, Paranoid Type |
2.1% |
| Blood Pressure |
1.0% |
| Lower Respiratory Tract Infection |
1.0% |
| Nail Disorder |
1.0% |
| Oedema Peripheral |
1.0% |
| Overdose |
1.0% |
| Sinus Tachycardia |
1.0% |
|
| Blood Prolactin Increased |
12.0% |
| White Blood Cell Count Increased |
12.0% |
| Incorrect Dose Administered |
8.0% |
| Treatment Noncompliance |
8.0% |
| Breast Cancer Female |
4.0% |
| Death |
4.0% |
| Neuroleptic Malignant Syndrome |
4.0% |
| Oropharyngeal Pain |
4.0% |
| Overdose |
4.0% |
| Oxygen Saturation Decreased |
4.0% |
| Psychotic Disorder |
4.0% |
| Pulmonary Embolism |
4.0% |
| Rash |
4.0% |
| Respiratory Depression |
4.0% |
| Tachycardia |
4.0% |
| Tardive Dyskinesia |
4.0% |
| Weight Decreased |
4.0% |
| Weight Increased |
4.0% |
| Wrong Drug Administered |
4.0% |
|
| Secondary |
| Schizophrenia |
28.3% |
| Product Used For Unknown Indication |
23.5% |
| Drug Abuse |
8.2% |
| Drug Use For Unknown Indication |
6.8% |
| Depression |
5.4% |
| Hypertension |
3.9% |
| Psychotic Disorder |
3.5% |
| Insomnia |
3.4% |
| Schizoaffective Disorder |
2.6% |
| Blood Cholesterol Increased |
2.1% |
| Schizophrenia, Paranoid Type |
2.1% |
| Hypothyroidism |
2.0% |
| Convulsion |
1.8% |
| Epilepsy |
1.5% |
| Affective Disorder |
0.9% |
| Salivary Hypersecretion |
0.9% |
| Diabetes Mellitus |
0.8% |
| Headache |
0.8% |
| Bipolar Disorder |
0.8% |
| Depressed Mood |
0.8% |
|
| White Blood Cell Count Increased |
17.2% |
| Platelet Count Decreased |
10.5% |
| Overdose |
8.0% |
| White Blood Cell Count Decreased |
5.8% |
| Weight Decreased |
4.9% |
| Neutropenia |
4.3% |
| Neutrophil Count Increased |
4.3% |
| Rash |
4.3% |
| Mental Impairment |
4.0% |
| Liver Function Test Abnormal |
3.7% |
| Vomiting |
3.7% |
| Haemoglobin Decreased |
3.4% |
| Hypertension |
3.4% |
| Sudden Death |
3.4% |
| Tachycardia |
3.4% |
| Weight Increased |
3.4% |
| Blood Prolactin Increased |
3.1% |
| Electrocardiogram Qt Prolonged |
3.1% |
| Neuroleptic Malignant Syndrome |
3.1% |
| Psychotic Disorder |
3.1% |
|
| Concomitant |
| Schizophrenia |
37.5% |
| Product Used For Unknown Indication |
11.9% |
| Drug Use For Unknown Indication |
8.6% |
| Depression |
6.3% |
| Psychotic Disorder |
5.5% |
| Hypertension |
3.9% |
| Schizophrenia, Paranoid Type |
3.7% |
| Diffuse Large B-cell Lymphoma |
3.3% |
| Affective Disorder |
3.0% |
| Schizoaffective Disorder |
2.3% |
| Constipation |
2.0% |
| Hypercholesterolaemia |
1.9% |
| Anxiety |
1.6% |
| Diabetes Mellitus |
1.6% |
| Psychiatric Symptom |
1.4% |
| Salivary Hypersecretion |
1.3% |
| Major Depression |
1.3% |
| Antibiotic Level |
0.9% |
| Ill-defined Disorder |
0.9% |
| Blood Cholesterol Increased |
0.9% |
|
| White Blood Cell Count Increased |
12.9% |
| White Blood Cell Count Decreased |
10.3% |
| Weight Increased |
9.3% |
| Vomiting |
8.0% |
| Loss Of Consciousness |
7.2% |
| Rhabdomyolysis |
6.7% |
| Tachycardia |
5.1% |
| Neutropenia |
3.9% |
| Overdose |
3.9% |
| Drug Interaction |
3.6% |
| Psychotic Disorder |
3.6% |
| Urinary Tract Infection |
3.6% |
| Somnolence |
3.3% |
| Urinary Incontinence |
3.3% |
| Death |
2.8% |
| Weight Decreased |
2.8% |
| Renal Failure |
2.6% |
| Sudden Death |
2.6% |
| Tremor |
2.6% |
| Neutrophil Count Decreased |
2.1% |
|
| Interacting |
| Drug Use For Unknown Indication |
30.5% |
| Schizophrenia |
21.1% |
| Staphylococcal Infection |
11.6% |
| Product Used For Unknown Indication |
6.3% |
| Hyperinsulinaemia |
4.2% |
| Mental Disorder |
4.2% |
| Lower Respiratory Tract Infection |
3.2% |
| Schizophrenia, Paranoid Type |
3.2% |
| Conduct Disorder |
2.1% |
| Depression |
2.1% |
| Extrapyramidal Disorder |
2.1% |
| Psychiatric Symptom |
2.1% |
| Schizophrenia, Disorganised Type |
2.1% |
| Weight Decreased |
2.1% |
| Bipolar Disorder |
1.1% |
| Depressive Symptom |
1.1% |
| Obesity |
1.1% |
|
| Hypertension |
30.6% |
| Drug Interaction |
13.9% |
| Rash |
13.9% |
| Rhabdomyolysis |
11.1% |
| Heart Rate Increased |
5.6% |
| Hyperventilation |
5.6% |
| Hyperprolactinaemia |
2.8% |
| Orchitis |
2.8% |
| Psychotic Disorder |
2.8% |
| Status Epilepticus |
2.8% |
| Tachycardia |
2.8% |
| Torsade De Pointes |
2.8% |
| Treatment Noncompliance |
2.8% |
|
